Relmada Therapeutics, Inc.
2020 Q2 - 2026 Q2 (13 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q2 | 8/24/2026 | 9 | 0.0% | 1,302 | 6/30/2026 |
| 2023 Q1 | 5/9/2023 | 23 | 0.0% | 10,183 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 38 | 0.0% | 10,934 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 1,117 | 0.0% | 30,171 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 541 | 0.0% | 28,507 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 843 | 0.0% | 31,222 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 639 | 0.0% | 28,366 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 463 | 0.0% | 17,656 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 663 | 0.0% | 20,724 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 778 | 0.0% | 22,104 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 710 | 0.0% | 22,130 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 821 | 0.0% | 21,832 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 949 | 0.0% | 21,198 | 6/30/2020 |